215 related articles for article (PubMed ID: 3780047)
1. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A
Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047
[TBL] [Abstract][Full Text] [Related]
2. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
Lampinen M; Oberg G; Venge P; Carlson M
APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
[TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity of human eosinophil chemotactic lymphokines.
Hirashima M; Ueno M; Kamiya K; Higuchi S; Matsumoto R
Lymphokine Cytokine Res; 1991 Dec; 10(6):481-6. PubMed ID: 1804311
[TBL] [Abstract][Full Text] [Related]
4. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
McEwen BJ; Wilcock BP; Eyre P
Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice. II. Physicochemical heterogeneity of eosinophil chemotactic lymphokines selective to bone marrow- or peritoneal exudate-eosinophils.
Owhashi M; Nawa Y
Int Arch Allergy Appl Immunol; 1987; 83(3):290-5. PubMed ID: 3110075
[TBL] [Abstract][Full Text] [Related]
6. [Generation of eosinophil chemotactic factor of anaphylaxis in patients with cold urticaria and study of its in vitro chemotactic deactivation].
Ibáñez MD; Leyva Cobián F; Díaz Gómez ML
Med Clin (Barc); 1986 May; 86(19):794-7. PubMed ID: 3736185
[No Abstract] [Full Text] [Related]
7. The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration.
Wadee AA; Sher R
Immunology; 1980 Dec; 41(4):989-95. PubMed ID: 7461720
[TBL] [Abstract][Full Text] [Related]
8. Variations in protein expression related to human eosinophil heterogeneity.
Gruart V; Balloul JM; Prin L; Tomassini M; Loiseau S; Capron A; Capron M
J Immunol; 1989 Jun; 142(12):4416-21. PubMed ID: 2723435
[TBL] [Abstract][Full Text] [Related]
9. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic heterogeneity of eosinophils in Kimura's disease.
Saita N; Ueno M; Yoshida M; Kimura T; Ando M; Hirashima M
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):21-3. PubMed ID: 8155998
[TBL] [Abstract][Full Text] [Related]
11. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
Tamura N; Agrawal DK; Suliaman FA; Townley RG
Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil and neutrophil chemotactic activities of adult worm extracts of Schistosoma japonicum in vivo and in vitro.
Horii Y; Owhashi M; Ishii A; Bandou K; Usui M
J Parasitol; 1984 Dec; 70(6):955-61. PubMed ID: 6098637
[TBL] [Abstract][Full Text] [Related]
14. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
Hirashima M; Tashiro K; Hayashi H
Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742
[TBL] [Abstract][Full Text] [Related]
15. Isolation and partial characterization of an eosinophil chemotactic factor from metacestodes of Taenia taeniaeformis (ECF-Tt).
Potter KA; Leid RW
J Immunol; 1986 Mar; 136(5):1712-7. PubMed ID: 3512706
[TBL] [Abstract][Full Text] [Related]
16. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
17. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects.
Grzegorczyk J; Majkowska-Wojciechowska B; Kowalski ML
Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil kinetics in the hypereosinophilic syndrome.
Dale DC; Hubert RT; Fauci A
J Lab Clin Med; 1976 Mar; 87(3):487-95. PubMed ID: 1249478
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic responsiveness of eosinophils isolated from patients with inflammatory skin diseases.
Morita E; Schröder JM; Christophers E
J Dermatol; 1989 Oct; 16(5):348-51. PubMed ID: 2532224
[TBL] [Abstract][Full Text] [Related]
20. Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).
Tai PC; Spry CJ
Clin Exp Immunol; 1980 Apr; 40(1):206-19. PubMed ID: 6993078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
